お知らせ :東京証券取引所JASDAQスタンダード市場への新規上場に関するお知らせ

株式会社グローバルインフォメーション
表紙
市場調査レポート
商品コード
977741

新型コロナウィルス感染症(COVID-19)診断の世界市場:製品およびサービス(機器、試薬およびキット、サービス)別、サンプルタイプ別、検査タイプ別、モード別、最終用途別の市場規模、シェアおよび動向分析、セグメント別予測(2021年~2027年)

COVID-19 Diagnostics Market Size, Share & Trends Analysis Report By Product & Service (Instruments, Reagents & Kits, Services), By Sample Type, By Test Type, By Mode, By End Use, And Segment Forecasts, 2021 - 2027

出版日: | 発行: Grand View Research, Inc. | ページ情報: 英文 150 Pages | 納期: 2-3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=104.84円
新型コロナウィルス感染症(COVID-19)診断の世界市場:製品およびサービス(機器、試薬およびキット、サービス)別、サンプルタイプ別、検査タイプ別、モード別、最終用途別の市場規模、シェアおよび動向分析、セグメント別予測(2021年~2027年)
出版日: 2020年12月11日
発行: Grand View Research, Inc.
ページ情報: 英文 150 Pages
納期: 2-3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の新型コロナウィルス感染症(COVID-19)診断の市場規模は、2021年から2027年にかけて3.1%のCAGRで拡大し、2027年までに1,047億米ドルに達すると予想されています。新型コロナウイルス感染症症例の増加する負担を効果的に管理するためには検査は極めて重要であるため、検査の実施率は急激に増加しています。 2020年11月の時点で米国で1億5,000万回以上の検査が実施され、続いてインドで1億回以上の検査が実施され、ブラジルで約2,000万回の検査が実施されました。

ポイントオブケア(PoC)Covid-19検査へのパラダイムシフトは、近い将来の市場拡大に大きな勢いをもたらすと推定されています。ポイントオブケア(POC)検査により、緊急治療センター、病院、診療所、救急治療室などの患者ケア環境で、正確なリアルタイムのラボ品質の診断結果が得られます。パンデミックに対応して、多くの診断検査メーカーは、実験室環境外での検査を容易にするために、迅速で使いやすいPOC COVID-19診断検査の開発に注力しています。

当レポートでは、世界の新型コロナウィルス感染症(COVID-19)診断市場について調査分析し、市場および業界の見通し、セグメント別・地域別の見通しのほか、競合情勢について、体系的な情報を提供しています。

目次

第1章 調査方法と範囲

第2章 エグゼクティブサマリー

第3章 業界の見通し

  • 親市場
  • 技術の浸透と成長の見通しのマッピング、2020年
  • 市場力学
    • 市場成長要因分析
    • 市場抑制分析
    • 市場機会分析
    • 市場課題分析
  • COVID-19診断市場-ポーターの分析
    • ポーターの分析
  • COVID-19診断市場- SWOT分析
    • 政治的および法的
    • 経済的
    • 技術的
  • COVID-19診断:企業の位置分析
  • COVID-19診断:各国の医療費と資金調達のシナリオ
    • 米国
    • 中国
    • ブラジル
    • ドイツ
    • その他
  • COVID-19診断市場-規制の枠組み
  • スワブ市場への影響
    • ウイルス輸送媒体の生産不足
    • ウイルス輸送媒体市場をリードする企業

第4章 製品とサービス別市場の分析

  • COVID-19診断市場:製品とサービス別市場の動向分析
  • 試薬とキット
  • 器具
  • サービス

第5章 サンプルタイプ別市場の分析

  • COVID-19診断市場:サンプルタイプ別市場の動向分析
  • 鼻咽頭(NP)綿棒
  • 中咽頭(OP)綿棒
  • 鼻腔スワブ
  • 血液
  • その他

第6章 検査タイプ別市場の分析

  • COVID-19診断市場:検査タイプ別市場の動向分析
  • 分子(PCR)検査
  • 抗原ベースの検査
  • 抗体(血清学)検査
  • その他

第7章 モード別市場の分析

  • COVID-19診断市場:モード別市場の動向分析
  • ポイントオブケア(PoC)検査
  • 非ポイントオブケア(非PoC)検査

第8章 最終用途別市場の分析

  • COVID-19診断市場:最終用途別市場の動向分析
  • 研究所
  • 病院
  • 診断センターとクリニック
  • その他

第9章 地域別市場の分析

  • COVID-19診断市場:地域別市場の動向分析、2020年および2027年
  • 北米
  • 欧州
  • アジア太平洋地域
  • ラテンアメリカ
  • 中東・アフリカ(MEA)

第10章 競合情勢

  • 企業 / 競合分類(主要イノベーター、市場リーダー、新興企業)
  • 戦略の枠組み
  • 市場参入の分類
  • 主要企業別最新動向およびインパクト解析
  • 企業プロファイル
    • F. Hoffmann-La Roche AG
    • Thermo Fisher Scientific, Inc.
    • PerkinElmer, Inc.
    • 1drop, Inc.
    • Veredus Laboratories
    • ADT Biotech Sdn Bhd
    • altona Diagnostics GmbH
    • bioMerieux SA
    • Neuberg Diagnostics
    • Abbott Laboratories
    • Luminex Corporation
    • Laboratory Corporation of America Holdings
    • Hologic Inc.
    • Quest Diagnostics, Inc.
    • Quidel Corporation
    • ALDATU BIOSCIENCES
    • Mylab Discovery Solutions Pvt. Ltd.
    • Danaher Corporation
図表

List of Tables

  • TABLE 1 List of secondary sources
  • TABLE 2 Incidence rate of COVID-19 in North America
  • TABLE 3 Incidence rate of COVID-19 in Europe
  • TABLE 4 Incidence rate of COVID-19 in Asia Pacific
  • TABLE 5 Incidence rate of COVID-19 in Latin America
  • TABLE 6 Incidence rate of COVID-19 in Middle East and Africa
  • TABLE 7 Specimen collection and storage for COVID-19 testing
  • TABLE 8 Different COVID-19 diagnostic tests based on different technologies
  • TABLE 9 North America COVID-19 diagnostics market estimates and forecasts, by product & service, 2020 - 2027 (USD Million)
  • TABLE 10 North America COVID-19 diagnostics market estimates and forecasts, by sample type, 2020 - 2027 (USD Million)
  • TABLE 11 North America COVID-19 diagnostics market estimates and forecasts, by test type, 2020 - 2027 (USD Million)
  • TABLE 12 North America COVID-19 diagnostics market estimates and forecasts, by mode, 2020 - 2027 (USD Million)
  • TABLE 13 North America COVID-19 diagnostics market estimates and forecasts, by end-use, 2020 - 2027 (USD Million)
  • TABLE 14 U.S. COVID-19 diagnostics market estimates and forecasts, by product & service, 2020 - 2027 (USD Million)
  • TABLE 15 U.S. COVID-19 diagnostics market estimates and forecasts, by sample type, 2020 - 2027 (USD Million)
  • TABLE 16 U.S. COVID-19 diagnostics market estimates and forecasts, by test type, 2020 - 2027 (USD Million)
  • TABLE 17 U.S. COVID-19 diagnostics market estimates and forecasts, by mode, 2020 - 2027 (USD Million)
  • TABLE 18 U.S. COVID-19 diagnostics market estimates and forecasts, by end-use, 2020 - 2027 (USD Million)
  • TABLE 19 Canada COVID-19 diagnostics market estimates and forecasts, by product & service, 2020 - 2027 (USD Million)
  • TABLE 20 Canada COVID-19 diagnostics market estimates and forecasts, by sample type, 2020 - 2027 (USD Million)
  • TABLE 21 Canada COVID-19 diagnostics market estimates and forecasts, by test type, 2020 - 2027 (USD Million)
  • TABLE 21 Canada COVID-19 diagnostics market estimates and forecasts, by mode, 2020 - 2027 (USD Million)
  • TABLE 23 Canada COVID-19 diagnostics market estimates and forecasts, by end-use, 2020 - 2027 (USD Million)
  • TABLE 24 Europe COVID-19 diagnostics market estimates and forecasts, by product & service, 2020 - 2027 (USD Million)
  • TABLE 25 Europe COVID-19 diagnostics market estimates and forecasts, by sample type, 2020 - 2027 (USD Million)
  • TABLE 26 Europe COVID-19 diagnostics market estimates and forecasts, by test type, 2020 - 2027 (USD Million)
  • TABLE 27 Europe COVID-19 diagnostics market estimates and forecasts, by mode, 2020 - 2027 (USD Million)
  • TABLE 28 Europe COVID-19 diagnostics market estimates and forecasts, by end-use, 2020 - 2027 (USD Million)
  • TABLE 29 Germany COVID-19 diagnostics market estimates and forecasts, by product & service, 2020 - 2027 (USD Million)
  • TABLE 30 Germany COVID-19 diagnostics market estimates and forecasts, by sample type, 2020 - 2027 (USD Million)
  • TABLE 31 Germany COVID-19 diagnostics market estimates and forecasts, by test type, 2020 - 2027 (USD Million)
  • TABLE 32 Germany COVID-19 diagnostics market estimates and forecasts, by mode, 2020 - 2027 (USD Million)
  • TABLE 33 Germany COVID-19 diagnostics market estimates and forecasts, by end-use, 2020 - 2027 (USD Million)
  • TABLE 34 U.K. COVID-19 diagnostics market estimates and forecasts, by product & service, 2020 - 2027 (USD Million)
  • TABLE 35 U.K. COVID-19 diagnostics market estimates and forecasts, by sample type, 2020 - 2027 (USD Million)
  • TABLE 36 U.K. COVID-19 diagnostics market estimates and forecasts, by test type, 2020 - 2027 (USD Million)
  • TABLE 37 U.K. COVID-19 diagnostics market estimates and forecasts, by mode, 2020 - 2027 (USD Million)
  • TABLE 38 U.K. COVID-19 diagnostics market estimates and forecasts, by end-use, 2020 - 2027 (USD Million)
  • TABLE 39 France COVID-19 diagnostics market estimates and forecasts, by product & service, 2020 - 2027 (USD Million)
  • TABLE 40 France COVID-19 diagnostics market estimates and forecasts, by sample type, 2020 - 2027 (USD Million)
  • TABLE 41 France COVID-19 diagnostics market estimates and forecasts, by test type, 2020 - 2027 (USD Million)
  • TABLE 42 France COVID-19 diagnostics market estimates and forecasts, by mode, 2020 - 2027 (USD Million)
  • TABLE 43 France COVID-19 diagnostics market estimates and forecasts, by end-use, 2020 - 2027 (USD Million)
  • TABLE 44 Italy COVID-19 diagnostics market estimates and forecasts, by product & service, 2020 - 2027 (USD Million)
  • TABLE 45 Italy COVID-19 diagnostics market estimates and forecasts, by sample type, 2020 - 2027 (USD Million)
  • TABLE 46 Italy COVID-19 diagnostics market estimates and forecasts, by test type, 2020 - 2027 (USD Million)
  • TABLE 47 Italy COVID-19 diagnostics market estimates and forecasts, by mode, 2020 - 2027 (USD Million)
  • TABLE 48 Italy COVID-19 diagnostics market estimates and forecasts, by end-use, 2020 - 2027 (USD Million)
  • TABLE 49 Spain COVID-19 diagnostics market estimates and forecasts, by product & service, 2020 - 2027 (USD Million)
  • TABLE 50 Spain COVID-19 diagnostics market estimates and forecasts, by sample type, 2020 - 2027 (USD Million)
  • TABLE 51 Spain COVID-19 diagnostics market estimates and forecasts, by test type, 2020 - 2027 (USD Million)
  • TABLE 52 Spain COVID-19 diagnostics market estimates and forecasts, by mode, 2020 - 2027 (USD Million)
  • TABLE 53 Spain COVID-19 diagnostics market estimates and forecasts, by end-use, 2020 - 2027 (USD Million)
  • TABLE 54 Russia COVID-19 diagnostics market estimates and forecasts, by product & service, 2020 - 2027 (USD Million)
  • TABLE 55 Russia COVID-19 diagnostics market estimates and forecasts, by sample type, 2020 - 2027 (USD Million)
  • TABLE 56 Russia COVID-19 diagnostics market estimates and forecasts, by test type, 2020 - 2027 (USD Million)
  • TABLE 57 Russia COVID-19 diagnostics market estimates and forecasts, by mode, 2020 - 2027 (USD Million)
  • TABLE 58 Russia COVID-19 diagnostics market estimates and forecasts, by end-use, 2020 - 2027 (USD Million)
  • TABLE 59 Asia Pacific COVID-19 diagnostics market estimates and forecasts, by product & service, 2020 - 2027 (USD Million)
  • TABLE 60 Asia Pacific COVID-19 diagnostics market estimates and forecasts, by sample type, 2020 - 2027 (USD Million)
  • TABLE 61 Asia Pacific COVID-19 diagnostics market estimates and forecasts, by test type, 2020 - 2027 (USD Million)
  • TABLE 62 Asia Pacific COVID-19 diagnostics market estimates and forecasts, by mode, 2020 - 2027 (USD Million)
  • TABLE 63 Asia Pacific COVID-19 diagnostics market estimates and forecasts, by end-use, 2020 - 2027 (USD Million)
  • TABLE 64 China COVID-19 diagnostics market estimates and forecasts, by product & service, 2020 - 2027 (USD Million)
  • TABLE 65 China COVID-19 diagnostics market estimates and forecasts, by sample type, 2020 - 2027 (USD Million)
  • TABLE 66 China COVID-19 diagnostics market estimates and forecasts, by test type, 2020 - 2027 (USD Million)
  • TABLE 67 China COVID-19 diagnostics market estimates and forecasts, by mode, 2020 - 2027 (USD Million)
  • TABLE 68 China COVID-19 diagnostics market estimates and forecasts, by end-use, 2020 - 2027 (USD Million)
  • TABLE 69 India COVID-19 diagnostics market estimates and forecasts, by product & service, 2020 - 2027 (USD Million)
  • TABLE 70 India COVID-19 diagnostics market estimates and forecasts, by sample type, 2020 - 2027 (USD Million)
  • TABLE 71 India COVID-19 diagnostics market estimates and forecasts, by test type, 2020 - 2027 (USD Million)
  • TABLE 72 India COVID-19 diagnostics market estimates and forecasts, by end-use, 2020 - 2027 (USD Million)
  • TABLE 73 Japan COVID-19 diagnostics market estimates and forecasts, by product & service, 2020 - 2027 (USD Million)
  • TABLE 74 Japan COVID-19 diagnostics market estimates and forecasts, by sample type, 2020 - 2027 (USD Million)
  • TABLE 75 Japan COVID-19 diagnostics market estimates and forecasts, by test type, 2020 - 2027 (USD Million)
  • TABLE 76 Japan COVID-19 diagnostics market estimates and forecasts, by mode, 2020 - 2027 (USD Million)
  • TABLE 77 Japan COVID-19 diagnostics market estimates and forecasts, by end-use, 2020 - 2027 (USD Million)
  • TABLE 78 South Korea COVID-19 diagnostics market estimates and forecasts, by product & service, 2020 - 2027 (USD Million)
  • TABLE 79 South Korea COVID-19 diagnostics market estimates and forecasts, by sample type, 2020 - 2027 (USD Million)
  • TABLE 80 South Korea COVID-19 diagnostics market estimates and forecasts, by test type, 2020 - 2027 (USD Million)
  • TABLE 81 South Korea COVID-19 diagnostics market estimates and forecasts, by mode, 2020 - 2027 (USD Million)
  • TABLE 82 South Korea COVID-19 diagnostics market estimates and forecasts, by end-use, 2020 - 2027 (USD Million)
  • TABLE 83 Australia COVID-19 diagnostics market estimates and forecasts, by product & service, 2020 - 2027 (USD Million)
  • TABLE 84 Australia COVID-19 diagnostics market estimates and forecasts, by sample type, 2020 - 2027 (USD Million)
  • TABLE 85 Australia COVID-19 diagnostics market estimates and forecasts, by test type, 2020 - 2027 (USD Million)
  • TABLE 86 Australia COVID-19 diagnostics market estimates and forecasts, by mode, 2020 - 2027 (USD Million)
  • TABLE 87 Australia COVID-19 diagnostics market estimates and forecasts, by end-use, 2020 - 2027 (USD Million)
  • TABLE 88 Latin America COVID-19 diagnostics market estimates and forecasts, by product & service, 2020 - 2027 (USD Million)
  • TABLE 89 Latin America COVID-19 diagnostics market estimates and forecasts, by sample type, 2020 - 2027 (USD Million)
  • TABLE 90 Latin America COVID-19 diagnostics market estimates and forecasts, by test type, 2020 - 2027 (USD Million)
  • TABLE 91 Latin America COVID-19 diagnostics market estimates and forecasts, by mode, 2020 - 2027 (USD Million)
  • TABLE 92 Latin America COVID-19 diagnostics market estimates and forecasts, by end-use, 2020 - 2027 (USD Million)
  • TABLE 93 Brazil COVID-19 diagnostics market estimates and forecasts, by product & service, 2020 - 2027 (USD Million)
  • TABLE 94 Brazil COVID-19 diagnostics market estimates and forecasts, by sample type, 2020 - 2027 (USD Million)
  • TABLE 95 Brazil COVID-19 diagnostics market estimates and forecasts, by test type, 2020 - 2027 (USD Million)
  • TABLE 96 Brazil COVID-19 diagnostics market estimates and forecasts, by mode, 2020 - 2027 (USD Million)
  • TABLE 97 Brazil COVID-19 diagnostics market estimates and forecasts, by end-use, 2020 - 2027 (USD Million)
  • TABLE 98 Mexico COVID-19 diagnostics market estimates and forecasts, by product & service, 2020 - 2027 (USD Million)
  • TABLE 99 Mexico COVID-19 diagnostics market estimates and forecasts, by sample type, 2020 - 2027 (USD Million)
  • TABLE 100 Mexico COVID-19 diagnostics market estimates and forecasts, by test type, 2020 - 2027 (USD Million)
  • TABLE 101 Mexico COVID-19 diagnostics market estimates and forecasts, by mode, 2020 - 2027 (USD Million)
  • TABLE 102 Mexico COVID-19 diagnostics market estimates and forecasts, by end-use, 2020 - 2027 (USD Million)
  • TABLE 103 MEA COVID-19 diagnostics market estimates and forecasts, by product & service, 2020 - 2027 (USD Million)
  • TABLE 104 MEA COVID-19 diagnostics market estimates and forecasts, by sample type, 2020 - 2027 (USD Million)
  • TABLE 105 MEA COVID-19 diagnostics market estimates and forecasts, by test type, 2020 - 2027 (USD Million)
  • TABLE 106 MEA COVID-19 diagnostics market estimates and forecasts, by mode, 2020 - 2027 (USD Million)
  • TABLE 107 MEA COVID-19 diagnostics market estimates and forecasts, by end-use, 2020 - 2027 (USD Million)
  • TABLE 108 South Africa COVID-19 diagnostics market estimates and forecasts, by product & service, 2020 - 2027 (USD Million)
  • TABLE 109 South Africa COVID-19 diagnostics market estimates and forecasts, by sample type, 2020 - 2027 (USD Million)
  • TABLE 110 South Africa COVID-19 diagnostics market estimates and forecasts, by test type, 2020 - 2027 (USD Million)
  • TABLE 111 South Africa COVID-19 diagnostics market estimates and forecasts, by mode, 2020 - 2027 (USD Million)
  • TABLE 112 South Africa COVID-19 diagnostics market estimates and forecasts, by end-use, 2020 - 2027 (USD Million)
  • TABLE 113 Saudi Arabia COVID-19 diagnostics market estimates and forecasts, by product & service, 2020 - 2027 (USD Million)
  • TABLE 114 Saudi Arabia COVID-19 diagnostics market estimates and forecasts, by sample type, 2020 - 2027 (USD Million)
  • TABLE 115 Saudi Arabia COVID-19 diagnostics market estimates and forecasts, by test type, 2020 - 2027 (USD Million)
  • TABLE 116 Saudi Arabia COVID-19 diagnostics market estimates and forecasts, by mode, 2020 - 2027 (USD Million)
  • TABLE 117 Saudi Arabia COVID-19 diagnostics market estimates and forecasts, by end-use, 2020 - 2027 (USD Million)

List of Figures

  • FIG. 1 Market research process
  • FIG. 2 Data triangulation techniques
  • FIG. 3 Primary research pattern
  • FIG. 4 Market research approaches
  • FIG. 5 Value-chain-based sizing & forecasting
  • FIG. 6 QFD modeling for market share assessment
  • FIG. 7 Market formulation & validation
  • FIG. 8 Market revenue modeling
  • FIG. 9 Market revenue modeling: Considerations
  • FIG. 10 Market revenue modeling: Considerations
  • FIG. 11 Market snapshot, 2020 (USD Million)
  • FIG. 12 COVID-19 diagnostics market segmentation
  • FIG. 13 Penetration & growth prospect mapping for technology, 2020
  • FIG. 14 Market driver relevance analysis (Current & future impact)
  • FIG. 15 Distribution of cases, as of 16th July 2020
  • FIG. 16 Distribution of cases, as of 4th June 2020
  • FIG. 17 Total number of cases in North America (1st March 2020-1st June 2020)
  • FIG. 18 Total number of cases in Europe (1st March 2020-1st June 2020)
  • FIG. 19 Total number of cases in Asia Pacific (excluding Oceania) (1st March 2020-1st June 2020)
  • FIG. 20 Total number of cases in Latin American countries (1st March 2020-1st June 2020)
  • FIG. 21 Total number of cases in South Africa (1st March 2020-1st June 2020)
  • FIG. 22 Market restrain relevance analysis (Current & future impact)
  • FIG. 23 Company Position Analysis
  • FIG. 24 Healthcare expenditure in China, 2013 - 2017
  • FIG. 25 Healthcare expenditure in Brazil, 2013 - 2017
  • FIG. 26 COVID-19 diagnostics market: Product & service outlook and key takeaways
  • FIG. 27 COVID-19 diagnostics market: Product & service movement analysis
  • FIG. 28 Global COVID-19 diagnostics reagents & kits market, 2020 - 2027 (USD Million)
  • FIG. 29 Global COVID-19 diagnostics instruments market, 2020 - 2027 (USD Million)
  • FIG. 30 Global COVID-19 diagnostic services market, 2020 - 2027 (USD Million)
  • FIG. 31 COVID-19 diagnostics market: Sample type outlook and key takeaways
  • FIG. 32 COVID-19 diagnostics market: Sample type movement analysis
  • FIG. 33 Global COVID-19 diagnostics nasopharyngeal swabs market, 2020 - 2027 (USD Million)
  • FIG. 34 Global COVID-19 diagnostics oropharyngeal swabs market, 2020 - 2027 (USD Million)
  • FIG. 35 Global COVID-19 diagnostics nasal swabs market, 2020 - 2027 (USD Million)
  • FIG. 36 Global COVID-19 diagnostics blood market, 2020 - 2027 (USD Million)
  • FIG. 37 Global COVID-19 diagnostics other samples market, 2020 - 2027 (USD Million)
  • FIG. 38 COVID-19 diagnostics market: Test type outlook and key takeaways
  • FIG. 39 COVID-19 diagnostics market: Test type movement analysis
  • FIG. 40 Global COVID-19 molecular (PCR) testing market, 2020 - 2027 (USD Million)
  • FIG. 41 Global COVID-19 antigen-based testing market, 2020 - 2027 (USD Million)
  • FIG. 42 Global COVID-19 antibody (Serology) testing market, 2020 - 2027 (USD Million)
  • FIG. 43 Global COVID-19 diagnostics other tests market, 2020 - 2027 (USD Million)
  • FIG. 44 COVID-19 diagnostics market: Mode outlook and key takeaways
  • FIG. 45 COVID-19 diagnostics market: Mode movement analysis
  • FIG. 46 Global COVID-19 Point-of-Care (PoC) testing market, 2020 - 2027 (USD Million)
  • FIG. 47 Global COVID-19 non Point-of-Care (Non-PoC) testing market, 2020 - 2027 (USD Million)
  • FIG. 48 COVID-19 diagnostics market: End-use outlook and key takeaways
  • FIG. 49 COVID-19 diagnostics market: End-use movement analysis
  • FIG. 50 Global laboratories-based COVID-19 diagnostics market, 2020 - 2027 (USD Million)
  • FIG. 51 Global hospitals-based COVID-19 diagnostics market, 2020 - 2027 (USD Million)
  • FIG. 52 Global diagnostic centers and clinics-based COVID-19 diagnostics market, 2020 - 2027 (USD Million)
  • FIG. 53 Global other end uses-based COVID-19 diagnostics market, 2020 - 2027 (USD Million)
  • FIG. 54 COVID-19 diagnostics market: Regional outlook and key takeaways
  • FIG. 55 COVID-19 diagnostics market: Regional movement analysis
  • FIG. 56 North America
  • FIG. 57 North America COVID-19 diagnostics market estimates and forecast, 2020 - 2027 (USD Million)
  • FIG. 58 U.S.
  • FIG. 59 U.S. COVID-19 diagnostics market estimates and forecast, 2020 - 2027 (USD Million)
  • FIG. 60 Canada
  • FIG. 61 Canada COVID-19 diagnostics market estimates and forecast, 2020 - 2027 (USD Million)
  • FIG. 62 Europe
  • FIG. 63 Europe COVID-19 diagnostics market estimates and forecast, 2020 - 2027 (USD Million)
  • FIG. 64 Germany
  • FIG. 65 Germany COVID-19 diagnostics market estimates and forecast, 2020 - 2027 (USD Million)
  • FIG. 66 U.K.
  • FIG. 67 U.K. COVID-19 diagnostics market estimates and forecast, 2020 - 2027 (USD Million)
  • FIG. 68 France
  • FIG. 69 France COVID-19 diagnostics market estimates and forecast, 2020 - 2027 (USD Million)
  • FIG. 70 Italy
  • FIG. 71 Italy COVID-19 diagnostics market estimates and forecast, 2020 - 2027 (USD Million)
  • FIG. 72 Spain
  • FIG. 73 Spain COVID-19 diagnostics market estimates and forecast, 2020 - 2027 (USD Million)
  • FIG. 74 Russia
  • FIG. 75 Russia COVID-19 diagnostics market estimates and forecast, 2020 - 2027 (USD Million)
  • FIG. 76 Asia Pacific
  • FIG. 77 Asia Pacific COVID-19 diagnostics market estimates and forecast, 2020 - 2027 (USD Million)
  • FIG. 78 China
  • FIG. 79 China COVID-19 diagnostics market estimates and forecast, 2020 - 2027 (USD Million)
  • FIG. 80 India
  • FIG. 81 India COVID-19 diagnostics market estimates and forecast, 2020 - 2027 (USD Million)
  • FIG. 82 Japan
  • FIG. 83 Japan COVID-19 diagnostics market estimates and forecast, 2020 - 2027 (USD Million)
  • FIG. 84 South Korea
  • FIG. 85 South Korea COVID-19 diagnostics market estimates and forecast, 2020 - 2027 (USD Million)
  • FIG. 86 Australia
  • FIG. 87 Australia COVID-19 diagnostics market estimates and forecast, 2020 - 2027 (USD Million)
  • FIG. 88 Latin America
  • FIG. 89 Latin America COVID-19 diagnostics market estimates and forecast, 2020 - 2027 (USD Million)
  • FIG. 90 Brazil
  • FIG. 91 Brazil COVID-19 diagnostics market estimates and forecast, 2020 - 2027 (USD Million)
  • FIG. 92 Mexico
  • FIG. 93 Mexico COVID-19 diagnostics market estimates and forecast, 2020 - 2027 (USD Million)
  • FIG. 94 Middle East & Africa
  • FIG. 95 MEA COVID-19 diagnostics market estimates and forecast, 2020 - 2027 (USD Million)
  • FIG. 96 South Africa
  • FIG. 97 South Africa COVID-19 diagnostics market estimates and forecast, 2020 - 2027 (USD Million)
  • FIG. 98 Saudi Arabia
  • FIG. 99 Saudi Arabia COVID-19 diagnostics market estimates and forecast, 2020 - 2027 (USD Million)
  • FIG. 100 Competition categorization
  • FIG. 101 Strategy framework
  • FIG. 102 Market participation categorization
目次
Product Code: GVR-4-68038-561-8

COVID-19 Diagnostics Market Growth & Trends:

The global COVID-19 diagnostics market size is expected to reach USD 104.7 billion by 2027, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 3.1% from 2021 to 2027. Since testing is pivotal for effective management of the rising burden of coronavirus cases, the rate at which testing is performed has witnessed a steep increase. More than 150 million tests have been performed in the U.S. as of November 2020, followed by more than 100 million tests conducted in India, and around 20 million tests performed in Brazil.

A paradigm shift towards point-of-care (PoC) Covid-19 testing is estimated to offer significant momentum to the market expansion in the near future. Point-of-care (POC) testing enables accurate real-time, lab-quality diagnostic results at patient care settings, such as urgent care centers, hospitals, clinics, and emergency rooms. In response to the pandemic, many diagnostic test manufacturers are focused on the development of rapid and easy-to-use POC COVID-19 diagnostic tests to facilitate testing outside of laboratory settings.

High investments by medical technology companies are expected to offer profitable opportunities for the coronavirus testing industry. These companies have witnessed a moderate to high spike in the revenue generated by the diagnostics/testing business segments in 2020, attributed to the pandemic outbreak. Such key industry entities have also witnessed a high influx of orders exceeding their manufacturing capacities, which has compelled these companies to increase their output by reorganizing their test production structures.

Expanding scales of COVID-19 testing are expected to be a boon for various medical technology companies operating in the market. Additionally, the government authorities are actively moving forward to scale up COVID-19 testing, further creating a favorable environment for emerging diagnostic companies and new entrants. Both smaller entities and multi-national companies have undertaken unprecedented mobilization to ensure timely availability of the tests.

Companies such as F. Hoffman-La Roche Ltd.; Thermo Fisher Scientific, Inc.; Perkin Elmer, Inc.; Laboratory Corporation of America Holdings; and Abbott have marked their presence in the market with highly efficient FDA-approved tests for coronavirus infection. The companies are implementing commercially viable strategies to gain a competitive advantage in the market. These include new test development, collaborations and partnerships with key stakeholders, and business expansion strategies to fulfill the demand of their customers across the globe.

High investments in the development as well as commercialization of antibody and antigen COVID-19 tests by key industry participants have been witnessed recently and this trend is expected to gain significant momentum in the coming years. For instance, in October 2020, Roche announced the launch of Elecsys SARS-CoV-2 Antigen test to support high volume COVID-19 testing of suspected patients. The test is anticipated to be available by the end of 2020 in the European market. Similarly, in October 2020, Thermo Fisher Scientific, Inc. launched two antibody tests, namely, OmniPATH COVID-19 Total Antibody ELISA and EliA SARS-CoV-2-Sp1 IgG tests for the screening of antibodies against the virus. This initiative was intended to expand the testing capabilities of the company against COVID-19.

COVID-19 Diagnostics Market Report Highlights:

  • By end use, diagnostic centers and clinics are estimated to witness the fastest growth from 2021 to 2027. This is attributed to the fact that the service providers are boosting their testing capabilities by expanding technological footprints in existing labs and diagnostic centers as well as by launching new, high-capacity laboratories
  • Based on sample type, nasopharyngeal swabs are estimated to account for 43.88% share in 2020. Nasopharyngeal swabs are the most preferred for COVID-19 sample collection. These swabs are employed in PCR-based COVID-19 tests at a large scale, boosting the segment's revenue generation capacity
  • In terms of mode, the PoC segment is expected to witness the fastest growth from 2021 to 2027. Increasing popularity of at-home testing and handheld instruments targeted toward combating the shortage of coronavirus test kits has been witnessed. This has propelled the adoption of PoC COVID-19 tests
  • The laboratories end-use segment is estimated to account for the largest share of 39.91% in 2020. The increasing number of laboratories are leveraging high-throughput technologies to process COVID-19 tests rapidly and effectively on a large scale. This is driven by effective implementation of favorable reimbursement policies in developed economies
  • Asia Pacific is projected to register the highest CAGR of 4.5% from 2021 to 2027. This is attributed to the robust funding for fast-track clinical validation studies with respect to rapid tests for COVID-19 diagnosis, along with minimizing the duration required to introduce novel products. The increasing pool of local diagnostic kits and reagents manufacturers providing testing solutions for COVID-19 detection is anticipated to contribute to revenue generation in the region

Table of Contents

Chapter 1 Methodology and Scope

  • 1.1 Research Methodology
  • 1.2 Research Assumptions
    • 1.2.1 Estimates and Forecast Timeline
  • 1.3 Information Procurement
    • 1.3.1 Purchased Database
    • 1.3.2 GVR's Internal Database
    • 1.3.3 Secondary Sources
    • 1.3.4 Primary Research
    • 1.3.5 Details of Primary Research
  • 1.4 Information or Data Analysis
    • 1.4.1 Data Analysis Models
  • 1.5 Market Formulation & Validation
  • 1.6 Model Details
    • 1.6.1 Commodity Flow Analysis
      • 1.6.1.1 Approach 1: Commodity Flow Approach
    • 1.6.2 Volume Price Analysis (Model 2)
      • 1.6.2.1 Approach 2: Volume Price Analysis
      • 1.6.2.2 revenue modeling
      • 1.6.2.3 Workflow mapping of covid-19 diagnostics
  • 1.7 List of Secondary Sources
  • 1.8 List of Primary Sources

Chapter 2 Executive Summary

  • 2.1 COVID-19 Diagnostics Market: Market Outlook
    • 2.1.1 Market Summary
  • 2.2 COVID-19 Diagnostics Market: Market Segmentation
  • 2.3 COVID-19 Diagnostics Market: Competitive Insights

Chapter 3 Industry Outlook

  • 3.1 Parent Market
  • 3.2 Penetration & Growth Prospect Mapping for Technology, 2020
  • 3.3 Market Dynamics
    • 3.3.1 Market driver analysis
      • 3.3.1.1 Increase in the incidence of coronavirus globally
      • 3.3.1.1.1 North America
      • 3.3.1.1.2 Europe
      • 3.3.1.1.3 Asia Pacific
      • 3.3.1.1.4 Latin America
      • 3.3.1.1.5 Middle East and Africa
      • 3.3.1.1 Increasing product approvals by regulatory agencies
      • 3.3.1.2 Government initiatives toward mass testing
      • 3.3.1.3 Paradigm shift toward POC testing
    • 3.3.2 Market restraint analysis
      • 3.3.2.1 Limited testing capacity
      • 3.3.2.1 Low demand due to supply ratio of COVID-19 reagents
    • 3.3.3 Market opportunity analysis
      • 3.3.3.1 Potential emerging markets
      • 3.3.3.2 Favorable reimbursement scenario
      • 3.3.3.3 Increasing penetration of telehealth in the diagnosis of Covid-19
    • 3.3.4 Market Challenge analysis
      • 3.3.4.1 Challenges pertaining to COVID-19 testing in healthcare settings
  • 3.4 COVID-19 Diagnostics Market - Porter's Analysis
    • 3.4.1 Porter's Analysis
      • 3.4.1.1 Competitive Rivalry - High
      • 3.4.1.2 Threat of New Entrants - MoDERATE
      • 3.4.1.3 Threat of Substitutes - Low
      • 3.4.1.4 Bargaining Power of Suppliers - Moderate
      • 3.4.1.5 Bargaining Power of Buyers - LoW
  • 3.5 COVID-19 Diagnostics Market - SWOT Analysis
    • 3.5.1 Political and Legal
      • 3.5.1.1 Strengths
      • 3.5.1.2 Weaknesses
      • 3.5.1.3 Opportunities
      • 3.5.1.4 Threats
    • 3.5.2 Economic
      • 3.5.2.1 Strengths
      • 3.5.2.2 Weakness
      • 3.5.2.3 Opportunity
      • 3.5.2.4 Threat
    • 3.5.3 Technological
      • 3.5.3.1 Strengths
      • 3.5.3.2 Weakness
      • 3.5.3.3 Opportunity
      • 3.5.3.4 Threat
  • 3.6 COVID-19 Diagnostics: Company Position Analysis
  • 3.7 COVID-19 Diagnostics: Healthcare Spending and Funding Scenario in Different Countries
    • 3.7.1 U.S.
    • 3.7.2 China
    • 3.7.3 Brazil
    • 3.7.4 Germany
    • 3.7.5 Others
  • 3.8 COVID-19 Diagnostics Market - Regulatory Framework
  • 3.9 Effect on Swabs Market
    • 3.9.1 Production shortage for viral transport media
    • 3.9.2 Companies leading the viral transport media market
      • 3.9.2.1 COPAN Diagnostics
      • 3.9.2.2 PURITAN MEDICAL PRODUCTS
      • 3.9.2.3 Becton, Dickinson and Company (BD)
      • 3.9.2.4 Thermo Fisher Scientific
      • 3.9.2.5 Other emerging companies

Chapter 4 Product & Service Business Analysis

  • 4.1 COVID-19 Diagnostics Market: Product & Service Movement Analysis
  • 4.2 Reagents & Kits
    • 4.2.1 Global COVID-19 Diagnostics reagents & kits market, 2020 - 2027 (USD Million)
  • 4.3 Instruments
    • 4.3.1 Global COVID-19 Diagnostics instruments market, 2020 - 2027 (USD Million)
  • 4.4 Services
    • 4.4.1 Global COVID-19 Diagnostic services market, 2020 - 2027 (USD Million)

Chapter 5 Sample Type Business Analysis

  • 5.1 COVID-19 Diagnostics Market: Sample Type Movement Analysis
  • 5.2 Nasopharyngeal (NP) Swabs
    • 5.2.1 Global COVID-19 Diagnostics nasopharyngeal swabs market, 2020 - 2027 (USD Million)
  • 5.3 Oropharyngeal (OP) Swabs
    • 5.3.1 Global COVID-19 Diagnostics oropharyngeal swabs market, 2020 - 2027 (USD Million)
  • 5.4 Nasal Swabs
    • 5.4.1 Global COVID-19 Diagnostics nasal swabs market, 2020 - 2027 (USD Million)
  • 5.5 Blood
    • 5.5.1 Global COVID-19 Diagnostics blood market, 2020 - 2027 (USD Million)
  • 5.6 Others
    • 5.6.1 Global COVID-19 Diagnostics other samples market, 2020 - 2027 (USD Million)

Chapter 6 Test Type Business Analysis

  • 6.1 COVID-19 Diagnostics Market: Test Type Movement Analysis
  • 6.2 Molecular (PCR) Testing
    • 6.2.1 Global COVID-19 molecular (PCR) testing market, 2020 - 2027 (USD Million)
  • 6.3 Antigen-based Testing
    • 6.3.1 Global COVID-19 antigen-based testing market, 2020 - 2027 (USD Million)
  • 6.4 Antibody (Serology) Testing
    • 6.4.1 Global COVID-19 Diagnostics antibody (Serology) testing market, 2020 - 2027 (USD Million)
  • 6.5 Others
    • 6.5.1 Global COVID-19 other tests market, 2020 - 2027 (USD Million)

Chapter 7 Mode Business Analysis

  • 7.1 COVID-19 Diagnostics Market: Mode Movement Analysis
  • 7.2 Point-of-Care (PoC) Testing
    • 7.2.1 Global COVID-19 Point-of-Care (PoC) testing market, 2020 - 2027 (USD Million)
  • 7.3 Non Point-of-Care (Non-PoC) Testing
    • 7.3.1 Global COVID-19 non Point-of-Care (Non-PoC) testing market, 2020 - 2027 (USD Million)

Chapter 8 END-USE Business Analysis

  • 8.1 COVID-19 Diagnostics Market: End-use Movement Analysis
  • 8.2 Laboratories
    • 8.2.1 Global laboratories-based COVID-19 Diagnostics market, 2020 - 2027 (USD Million)
  • 8.3 Hospitals
    • 8.3.1 Global hospitals-based COVID-19 Diagnostics market, 2020 - 2027 (USD Million)
  • 8.4 Diagnostic Centers and Clinics
    • 8.4.1 Global diagnostic centers and clinics-based COVID-19 Diagnostics market, 2020 - 2027 (USD Million)
  • 8.5 Others
    • 8.5.1 Global other end uses-based COVID-19 Diagnostics market, 2020 - 2027 (USD Million)

Chapter 9 Regional Business Analysis

  • 9.1 COVID-19 Diagnostics Market: Regional Movement Analysis, 2020 & 2027
  • 9.2 North America
    • 9.2.1 North America COVID-19 diagnostics market estimates and forecast, 2020 - 2027 (USD Million)
    • 9.2.2 U.S.
      • 9.2.2.1 U.S. COVID-19 diagnostics market estimates and forecast, by product & service, 2020 - 2027 (USD Million)
      • 9.2.2.2 U.S. COVID-19 diagnostics market estimates and forecast, by sample type, 2020 - 2027 (USD Million)
      • 9.2.2.3 U.S. COVID-19 diagnostics market estimates and forecast, by test type, 2020 - 2027 (USD Million)
      • 9.2.2.4 U.S. COVID-19 diagnostics market estimates and forecast, by mode, 2020 - 2027 (USD Million)
      • 9.2.2.5 U.S. COVID-19 diagnostics market estimates and forecast, by end-use, 2020 - 2027 (USD Million)
    • 9.2.3 Canada
      • 9.2.3.1 Canada COVID-19 diagnostics market estimates and forecast, by product & service, 2020 - 2027 (USD Million)
      • 9.2.3.2 Canada COVID-19 diagnostics market estimates and forecast, by sample type, 2020 - 2027 (USD Million)
      • 9.2.3.3 Canada COVID-19 diagnostics market estimates and forecast, by test type, 2020 - 2027 (USD Million)
      • 9.2.3.4 Canada COVID-19 diagnostics market estimates and forecast, by mode, 2020 - 2027 (USD Million)
      • 9.2.3.5 Canada COVID-19 diagnostics market estimates and forecast, by end-use, 2020 - 2027 (USD Million)
  • 9.3 Europe
    • 9.3.1 Europe COVID-19 diagnostics market estimates and forecast, 2020 - 2027 (USD Million)
    • 9.3.2 Germany
      • 9.3.2.1 Germany COVID-19 diagnostics market estimates and forecast, by product & service, 2020 - 2027 (USD Million)
      • 9.3.2.2 Germany COVID-19 diagnostics market estimates and forecast, by sample type, 2020 - 2027 (USD Million)
      • 9.3.2.3 Germany COVID-19 diagnostics market estimates and forecast, by test type, 2020 - 2027 (USD Million)
      • 9.3.2.4 Germany COVID-19 diagnostics market estimates and forecast, by mode, 2020 - 2027 (USD Million)
      • 9.3.2.5 Germany COVID-19 diagnostics market estimates and forecast, by end-use, 2020 - 2027 (USD Million)
    • 9.3.3 U.K.
      • 9.3.3.1 U.K. COVID-19 diagnostics market estimates and forecast, by product & service, 2020 - 2027 (USD Million)
      • 9.3.3.2 U.K. COVID-19 diagnostics market estimates and forecast, by sample type, 2020 - 2027 (USD Million)
      • 9.3.3.3 UK COVID-19 diagnostics market estimates and forecast, by test type, 2020 - 2027 (USD Million)
      • 9.3.3.4 U.K. COVID-19 diagnostics market estimates and forecast, by mode, 2020 - 2027 (USD Million)
      • 9.3.3.5 U.K. COVID-19 diagnostics market estimates and forecast, by end-use, 2020 - 2027 (USD Million)
    • 9.3.4 France
      • 9.3.4.1 France COVID-19 diagnostics market estimates and forecast, by product & service, 2020 - 2027 (USD Million)
      • 9.3.4.2 France COVID-19 diagnostics market estimates and forecast, by sample type, 2020 - 2027 (USD Million)
      • 9.3.4.3 France COVID-19 diagnostics market estimates and forecast, by test type, 2020 - 2027 (USD Million)
      • 9.3.4.4 France COVID-19 diagnostics market estimates and forecast, by mode, 2020 - 2027 (USD Million)
      • 9.3.4.5 France COVID-19 diagnostics market estimates and forecast, by end-use, 2020 - 2027 (USD Million)
    • 9.3.5 Italy
      • 9.3.5.1 Italy COVID-19 diagnostics market estimates and forecast, by product & service, 2020 - 2027 (USD Million)
      • 9.3.5.2 Italy COVID-19 diagnostics market estimates and forecast, by sample type, 2020 - 2027 (USD Million)
      • 9.3.5.3 Italy COVID-19 diagnostics market estimates and forecast, by test type, 2020 - 2027 (USD Million)
      • 9.3.5.4 Italy COVID-19 diagnostics market estimates and forecast, by mode, 2020 - 2027 (USD Million)
      • 9.3.5.5 Italy COVID-19 diagnostics market estimates and forecast, by end-use, 2020 - 2027 (USD Million)
    • 9.3.6 Spain
      • 9.3.6.1 Spain COVID-19 diagnostics market estimates and forecast, by product & service, 2020 - 2027 (USD Million)
      • 9.3.6.2 Spain COVID-19 diagnostics market estimates and forecast, by sample type, 2020 - 2027 (USD Million).
      • 9.3.6.3 Spain COVID-19 diagnostics market estimates and forecast, by test type, 2020 - 2027 (USD Million)
      • 9.3.6.4 Spain COVID-19 diagnostics market estimates and forecast, by mode, 2020 - 2027 (USD Million)
      • 9.3.6.5 Spain COVID-19 diagnostics market estimates and forecast, by end-use, 2020 - 2027 (USD Million)
    • 9.3.7 Russia
      • 9.3.7.1 Russia COVID-19 diagnostics market estimates and forecast, by product & service, 2020 - 2027 (USD Million)
      • 9.3.7.2 Russia COVID-19 diagnostics market estimates and forecast, by sample type, 2020 - 2027 (USD Million)
      • 9.3.7.3 Russia COVID-19 diagnostics market estimates and forecast, by test type, 2020 - 2027 (USD Million)
      • 9.3.7.4 Russia COVID-19 diagnostics market estimates and forecast, by mode, 2020 - 2027 (USD Million)
      • 9.3.7.5 Russia COVID-19 diagnostics market estimates and forecast, by end-use, 2020 - 2027 (USD Million)
  • 9.4 Asia Pacific
    • 9.4.1 Asia Pacific COVID-19 diagnostics market estimates and forecast, 2020 - 2027 (USD Million)
    • 9.4.2 China
      • 9.4.2.1 China COVID-19 diagnostics market estimates and forecast, by product & service, 2020 - 2027 (USD Million)
      • 9.4.2.2 China COVID-19 diagnostics market estimates and forecast, by sample type, 2020 - 2027 (USD Million)
      • 9.4.2.3 China COVID-19 diagnostics market estimates and forecast, by test type, 2020 - 2027 (USD Million)
      • 9.4.2.4 China COVID-19 diagnostics market estimates and forecast, by mode, 2020 - 2027 (USD Million)
      • 9.4.2.5 China COVID-19 diagnostics market estimates and forecast, by end-use, 2020 - 2027 (USD Million)
    • 9.4.3 India
      • 9.4.3.1 India COVID-19 diagnostics market estimates and forecast, by product & service, 2020 - 2027 (USD Million)
      • 9.4.3.2 India COVID-19 diagnostics market estimates and forecast, by sample type, 2020 - 2027 (USD Million)
      • 9.4.3.3 India COVID-19 diagnostics market estimates and forecast, by test type, 2020 - 2027 (USD Million)
      • 9.4.3.4 India COVID-19 diagnostics market estimates and forecast, by mode, 2020 - 2027 (USD Million)
      • 9.4.3.5 India COVID-19 diagnostics market estimates and forecast, by end-use, 2020 - 2027 (USD Million)
    • 9.4.4 Japan
      • 9.4.4.1 Japan COVID-19 diagnostics market estimates and forecast, by product & service, 2020 - 2027 (USD Million)
      • 9.4.4.2 Japan COVID-19 diagnostics market estimates and forecast, by sample type, 2020 - 2027 (USD Million)
      • 9.4.4.3 Japan COVID-19 diagnostics market estimates and forecast, by test type, 2020 - 2027 (USD Million)
      • 9.4.4.4 Japan COVID-19 diagnostics market estimates and forecast, by mode, 2020 - 2027 (USD Million)
      • 9.4.4.5 Japan COVID-19 diagnostics market estimates and forecast, by end-use, 2020 - 2027 (USD Million)
    • 9.4.5 South Korea
      • 9.4.5.1 South Korea COVID-19 diagnostics market estimates and forecast, by product & service, 2020 - 2027 (USD Million)
      • 9.4.5.2 South Korea COVID-19 diagnostics market estimates and forecast, by sample type, 2020 - 2027 (USD Million)
      • 9.4.5.3 South Korea COVID-19 diagnostics market estimates and forecast, by test type, 2020 - 2027 (USD Million)
      • 9.4.5.4 South Korea COVID-19 diagnostics market estimates and forecast, by mode, 2020 - 2027 (USD Million)
      • 9.4.5.5 South Korea COVID-19 diagnostics market estimates and forecast, by end-use, 2020 - 2027 (USD Million)
    • 9.4.6 Australia
      • 9.4.6.1 Australia COVID-19 diagnostics market estimates and forecast, by product & service, 2020 - 2027 (USD Million)
      • 9.4.6.2 Australia COVID-19 diagnostics market estimates and forecast, by sample type, 2020 - 2027 (USD Million)
      • 9.4.6.3 Australia COVID-19 diagnostics market estimates and forecast, by test type, 2020 - 2027 (USD Million)
      • 9.4.6.4 Australia COVID-19 diagnostics market estimates and forecast, by mode, 2020 - 2027 (USD Million)
      • 9.4.6.5 Australia COVID-19 diagnostics market estimates and forecast, by end-use, 2020 - 2027 (USD Million)
  • 9.5 Latin America
    • 9.5.1 Latin America COVID-19 diagnostics market estimates and forecast, 2020 - 2027 (USD Million)
    • 9.5.2 Brazil
      • 9.5.2.1 Brazil COVID-19 diagnostics market estimates and forecast, by product & service, 2020 - 2027 (USD Million)
      • 9.5.2.2 Brazil COVID-19 diagnostics market estimates and forecast, by sample type, 2020 - 2027 (USD Million)
      • 9.5.2.3 Brazil COVID-19 diagnostics market estimates and forecast, by test type, 2020 - 2027 (USD Million)
      • 9.5.2.4 Brazil COVID-19 diagnostics market estimates and forecast, by mode, 2020 - 2027 (USD Million)
      • 9.5.2.5 Brazil COVID-19 diagnostics market estimates and forecast, by end-use, 2020 - 2027 (USD Million)
    • 9.5.3 Mexico
      • 9.5.3.1 Mexico COVID-19 diagnostics market estimates and forecast, by product & service, 2020 - 2027 (USD Million)
      • 9.5.3.2 Mexico COVID-19 diagnostics market estimates and forecast, by sample type, 2020 - 2027 (USD Million)
      • 9.5.3.3 Mexico COVID-19 diagnostics market estimates and forecast, by test type, 2020 - 2027 (USD Million)
      • 9.5.3.4 Mexico COVID-19 diagnostics market estimates and forecast, by mode, 2020 - 2027 (USD Million)
      • 9.5.3.5 Mexico COVID-19 diagnostics market estimates and forecast, by end-use, 2020 - 2027 (USD Million)
  • 9.6 Middle East and Africa (MEA)
    • 9.6.1 MEA COVID-19 diagnostics market estimates and forecast, 2020 - 2027 (USD Million)
    • 9.6.2 South Africa
      • 9.6.2.1 South Africa COVID-19 diagnostics market estimates and forecast, by product & service, 2020 - 2027 (USD Million)
      • 9.6.2.2 South Africa COVID-19 diagnostics market estimates and forecast, by sample type, 2020 - 2027 (USD Million)
      • 9.6.2.3 South Africa COVID-19 diagnostics market estimates and forecast, by test type, 2020 - 2027 (USD Million)
      • 9.6.2.4 South Africa COVID-19 diagnostics market estimates and forecast, by mode, 2020 - 2027 (USD Million)
      • 9.6.2.5 South Africa COVID-19 diagnostics market estimates and forecast, by end-use, 2020 - 2027 (USD Million)
    • 9.6.3 Saudi Arabia
      • 9.6.3.1 Saudi Arabia COVID-19 diagnostics market estimates and forecast, by product & service, 2020 - 2027 (USD Million)
      • 9.6.3.2 Saudi Arabia COVID-19 diagnostics market estimates and forecast, by sample type, 2020 - 2027 (USD Million)
      • 9.6.3.3 South Africa COVID-19 diagnostics market estimates and forecast, by test type, 2020 - 2027 (USD Million)
      • 9.6.3.4 Saudi Arabia COVID-19 diagnostics market estimates and forecast, by mode, 2020 - 2027 (USD Million)
      • 9.6.3.5 Saudi Arabia COVID-19 diagnostics market estimates and forecast, by end-use, 2020 - 2027 (USD Million)

Chapter 10 Competitive Landscape

  • 10.1 Company/Competition Categorization (Key Innovators, Market leaders, Emerging Players)
  • 10.2 Strategy Framework
  • 10.3 Market Participation Categorization
  • 10.4 Recent Developments & Impact Analysis, by Key Market Participants
  • 10.5 Company Profiles
    • 10.5.1 F. Hoffmann-La Roche AG
      • 10.5.1.1 Company overview
      • 10.5.1.2 Financial performance
      • 10.5.1.3 Product benchmarking
      • 10.5.1.4 Strategic initiatives
    • 10.5.2 Thermo Fisher Scientific, Inc.
      • 10.5.2.1 Company overview
      • 10.5.2.2 Financial performance
      • 10.5.2.3 Product benchmarking
      • 10.5.2.4 Strategic initiatives
    • 10.5.3 PerkinElmer, Inc.
      • 10.5.3.1 Company overview
      • 10.5.3.2 Financial performance
      • 10.5.3.3 Product benchmarking
      • 10.5.3.4 Strategic initiatives
    • 10.5.4 1drop, Inc.
      • 10.5.4.1 Company overview
      • 10.5.4.2 Product benchmarking
      • 10.5.4.3 Strategic initiatives
    • 10.5.5 Veredus Laboratories
      • 10.5.5.1 Company overview
      • 10.5.5.2 Financial performance (Sekisui Chemical Co., Ltd.)
      • 10.5.5.3 Product benchmarking
      • 10.5.5.4 Strategic initiatives
    • 10.5.6 ADT Biotech Sdn Bhd
      • 10.5.6.1 Company overview
      • 10.5.6.2 Product benchmarking
      • 10.5.6.3 Strategic initiatives
    • 10.5.7 altona Diagnostics GmbH
      • 10.5.7.1 Company overview
      • 10.5.7.2 Product benchmarking
      • 10.5.7.3 Strategic initiatives
    • 10.5.8 bioMerieux SA
      • 10.5.8.1 Company overview
      • 10.5.8.2 Financial performance
      • 10.5.8.3 Product benchmarking
      • 10.5.8.4 Strategic initiatives
    • 10.5.9 Neuberg Diagnostics
      • 10.5.9.1 Company overview
      • 10.5.9.2 Product benchmarking
      • 10.5.9.3 Strategic initiatives
    • 10.5.10 Abbott Laboratories
      • 10.5.10.1 Company overview
      • 10.5.10.2 Financial performance
      • 10.5.10.3 Product benchmarking
      • 10.5.10.4 Strategic Initiatives
    • 10.5.11 Luminex Corporation
      • 10.5.11.1 Company overview
      • 10.5.11.2 Financial performance
      • 10.5.11.3 Product benchmarking
      • 10.5.11.4 Strategic Initiatives
    • 10.5.12 Laboratory Corporation of America Holdings
      • 10.5.12.1 Company overview
      • 10.5.12.2 Financial performance
      • 10.5.12.3 Product benchmarking
      • 10.5.12.4 Strategic Initiatives
    • 10.5.13 Hologic Inc.
      • 10.5.13.1 Company overview
      • 10.5.13.2 Financial performance
      • 10.5.13.3 Product benchmarking
      • 10.5.13.1 Strategic Initiatives
    • 10.5.14 Quest Diagnostics, Inc.
      • 10.5.14.1 Company overview
      • 10.5.14.2 Financial performance
      • 10.5.14.3 Product benchmarking
      • 10.5.14.4 Strategic Initiatives
    • 10.5.15 Quidel Corporation
      • 10.5.15.1 Company overview
      • 10.5.15.2 Financial performance
      • 10.5.15.3 Product benchmarking
      • 10.5.15.4 Strategic Initiatives
    • 10.5.16 ALDATU BIOSCIENCES
      • 10.5.16.1 Company overview
      • 10.5.16.2 Product benchmarking
      • 10.5.16.3 Strategic Initiatives
    • 10.5.17 Mylab Discovery Solutions Pvt. Ltd.
      • 10.5.17.1 Company overview
      • 10.5.17.2 Product benchmarking
      • 10.5.17.3 Strategic Initiatives
    • 10.5.18 Danaher Corporation
      • 10.5.18.1 Company overview
      • 10.5.18.2 Financial performance
      • 10.5.18.3 Cepheid
      • 10.5.18.3.1 Company overview
      • 10.5.18.3.2 Product benchmarking (Cepheid)
      • 10.5.18.3.3 Strategic Initiatives
      • 10.5.18.4 Beckman Coulter, Inc.
      • 10.5.18.4.1 Company overview
      • 10.5.18.4.2 Product benchmarking (Beckman Coulter)
      • 10.5.18.4.3 Strategic Initiatives
株式会社グローバルインフォメーション
© Copyright 1996-2021, Global Information, Inc. All rights reserved.